Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders
Pediatric Blood & Cancer · 2026
DOI: 10.1002/pbc.32131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Claire E F Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Primary Children's Hospital, University of Utah, Sa…. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Anemia, Sickle Cell, Central Nervous System Neoplasms, Social Determinants of Health. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NICHD NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
To investigate the role of social determinants of health (SDoH) in neurocognitive functioning among children with acute lymphoblastic leukemia (ALL), central nervous system (CNS) tumors, and sickle cell disease (SCD). Procedure Fifty‐eight child‐caregiver dyads participated. SDoH included components of socioeconomic status (SES; family income, caregiver education, and insurance type), race/ethnicity, caregiver marital status, and neighborhood‐level deprivation. Neurocognitive functioning was measured using the NIH Toolbox Cognition Battery (NIHTB‐CB) Fluid Cognition subtests.
Results
There were no differences in SDoH between the three diagnosis groups other than expected differences in race/ethnicity ( χ 2 (4, n = 51) = 46.1, p < 0.001). Bivariate analyses found a significant association between family income and working memory ( r = 0.31, p < 0.05), processing speed ( r = 0.29, p < 0.05), and fluid cognition composite scores ( r = 0.29, p < 0.05). No other SDoH were associated with neurocognitive functioning. Family income remained significantly associated with performance on working memory ( β = 0.35, p < 0.05), processing speed ( β = 0.33, p < 0.05), and fluid cognition composite scores ( β = 0.29, p < 0.05) after controlling for diagnosis, age, and sex.
Conclusions
Lower family income emerged as an important element of SES associated with poorer neurocognitive functioning in children treated for cancer and blood disorders. Further research is needed to determine how family income alters neurocognitive functioning, whether by altering the timing of emergence or the magnitude of deficits. Future studies should investigate mechanisms linking low income to neurocognitive performance to inform interventions to bolster neurocognitive development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA.
- Center For Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
- Population Health Shared Resource, University of Colorado Cancer Center, Aurora, Colorado, USA.
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Psychology and Human Development, Vanderbilt University, Nashville, Tennessee, USA.
Förderung
- NCI NIH HHS
- NICHD NIH HHS
Zitieren
APA
Miller, C. E. F., Luehring, J. N., Kuna, E. B. M., Bhatia, S., Green, A. L., & Compas, B. E. (2026). Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32131
Vancouver
Miller CEF, Luehring JN, Kuna EBM, Bhatia S, Green AL, Compas BE. Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32131
BibTeX
@article{Miller2026,
author = {Miller, Claire E F and Luehring, Jamie Neiman and Kuna, Elizabeth B Molina and Bhatia, Shweta and Green, Adam L and Compas, Bruce E},
title = {Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/pbc.32131}
}
EUVIMED